About this episode

The episode discusses the implications of the TrumpRx proposal on drug pricing and patient costs.

In this episode of Healthcare Matters , our hosts unpack the evolving conversation around drug pricing reform—focusing on a new proposal often referred to as “TrumpRx.” Drawing from Robert’s recent co-authored article The Promise of TrumpRx , they explore how direct-to-consumer purchasing, pricing transparency, and reforming the rebate-driven PBM system could reshape what patients actually pay at the pharmacy counter. Robert breaks down how PBMs influence list prices, why rebate contracting misaligns incentives, and how deductibles and co-insurance calculations leave many patients, especially those with chronic illnesses, paying more than they should. The conversation also outlines four key policy changes that would be necessary for any TrumpRx-style model to meaningfully benefit patients, including allowing cash prices to count toward deductibles and extending transparency to both employers and consumers. The conversation explores how upcoming policy shifts, including changes tied to the IRA, may influence drug affordability and how clearer pricing information could help patients make more informed decisions about their care. You can read Robert’s…

Topics covered

• drug pricing reform
• TrumpRx
• PBM system
• pricing transparency
• patient care
• health policy

Keywords

• drug pricing
• TrumpRx
• PBM
• pricing transparency
• health policy
• patient costs
• deductibles
• co-insurance

More episodes of Healthcare Matters

• S7, Ep 6- 340B Program & Hospital Charity Care: What Patients Need to Know · July 13, 2026 · 18 min
• S7, Ep 5- How ACIP Lawsuits are Impacting Patients: When Vaccine Guidance Becomes an Access Problem · May 20, 2026 · 21 min
• S7, Ep 4- COVID Antivirals: Are High-Risk Patients Missing the Window? · April 8, 2026 · 12 min
• S7, Ep 3- 340B: Are Patients Seeing the Savings? · April 1, 2026 · 15 min
• S7, Ep 2- PBM Reform at an Inflection Point: What Comes Next? · February 20, 2026 · 40 min
• S7, Ep 1- The $29 Billion Problem: Understanding Influenza's True Economic Toll · January 29, 2026 · 22 min

Explore listener stats, chart rankings, contacts and more on the Healthcare Matters podcast page.